These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans. Love TM; Stohler CS; Zubieta JK Arch Gen Psychiatry; 2009 Oct; 66(10):1124-34. PubMed ID: 19805703 [TBL] [Abstract][Full Text] [Related]
11. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study. Holland S; Fanning KM; Serrano D; Buse DC; Reed ML; Lipton RB J Neurol Sci; 2013 Mar; 326(1-2):10-7. PubMed ID: 23394974 [TBL] [Abstract][Full Text] [Related]
12. Persistent medication-induced neural adaptations, descending facilitation, and medication overuse headache. De Felice M; Ossipov MH; Porreca F Curr Opin Neurol; 2011 Jun; 24(3):193-6. PubMed ID: 21467931 [TBL] [Abstract][Full Text] [Related]
13. Presynaptic mechanism for anti-analgesic and anti-hyperalgesic actions of kappa-opioid receptors. Bie B; Pan ZZ J Neurosci; 2003 Aug; 23(19):7262-8. PubMed ID: 12917359 [TBL] [Abstract][Full Text] [Related]
14. 3D-neuronavigation in vivo through a patient's brain during a spontaneous migraine headache. DaSilva AF; Nascimento TD; Love T; DosSantos MF; Martikainen IK; Cummiford CM; DeBoer M; Lucas SR; Bender MA; Koeppe RA; Hall T; Petty S; Maslowski E; Smith YR; Zubieta JK J Vis Exp; 2014 Jun; (88):. PubMed ID: 24962460 [TBL] [Abstract][Full Text] [Related]
15. Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans. Scott DJ; Domino EF; Heitzeg MM; Koeppe RA; Ni L; Guthrie S; Zubieta JK Neuropsychopharmacology; 2007 Feb; 32(2):450-7. PubMed ID: 17091130 [TBL] [Abstract][Full Text] [Related]
16. Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications. Burford NT; Traynor JR; Alt A Br J Pharmacol; 2015 Jan; 172(2):277-86. PubMed ID: 24460691 [TBL] [Abstract][Full Text] [Related]
17. Drug Interaction and Serotonin Toxicity with Opioid Use: Another Reason to Avoid Opioids in Headache and Migraine Treatment. Ansari H; Kouti L Curr Pain Headache Rep; 2016 Aug; 20(8):50. PubMed ID: 27457368 [TBL] [Abstract][Full Text] [Related]
18. Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans. Prossin AR; Zalcman SS; Heitzeg MM; Koch AE; Campbell PL; Phan KL; Stohler CS; Zubieta JK Neuropsychopharmacology; 2015 Feb; 40(3):554-65. PubMed ID: 25139063 [TBL] [Abstract][Full Text] [Related]
19. Opioid Treatment of Migraine: Risk Factors and Behavioral Issues. Stone MT; Weed V; Kulich RJ Curr Pain Headache Rep; 2016 Sep; 20(9):51. PubMed ID: 27474093 [TBL] [Abstract][Full Text] [Related]
20. Oral transmucosal fentanyl citrate for the treatment of migraine headache pain in outpatients: a case series. Landy SH Headache; 2004 Sep; 44(8):762-6. PubMed ID: 15330821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]